Ident. | Authors (with country if any) | Title |
---|
000830 (2019) |
Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Keiji Maeda [Japon] | Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis. |
000B11 (2019) |
Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon] | Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study. |
000C23 (2019) |
Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Kazuyuki Yoshizaki [Japon] | IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. |
001511 (2018) |
Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] | A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period. |
001757 (2017) |
Gerd R. Burmester [Allemagne] ; Ernest Choy [Royaume-Uni] ; Alan Kivitz [États-Unis] ; Atsushi Ogata [Japon] ; Min Bao [États-Unis] ; Akira Nomura [Japon] ; Stuart Lacey [Royaume-Uni] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Navita L. Mallalieu [États-Unis] ; Thomas Wallace [États-Unis] ; Margaret Michalska [États-Unis] ; Herbert Birnboeck [Suisse] ; Kay Stubenrauch [Allemagne] ; Mark C. Genovese [États-Unis] | Low immunogenicity of tocilizumab in patients with rheumatoid arthritis. |
001A11 (2016) |
Takayoshi Morita [Japon] ; Yoshihito Shima [Japon] ; James Badger Wing [Japon] ; Shimon Sakaguchi [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis |
001E94 (2015) |
Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon] | Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
001F01 (2015) |
Atsushi Ogata [Japon] ; Takayoshi Morita ; Yuji Yoshida ; Toshio Tanaka | Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis. |
001F70 (2015) |
Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira Nomura | Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study. |
001F75 (2015) |
Minoru Fujimoto [Japon] ; Satoshi Serada [Japon] ; Katsuya Suzuki [Japon] ; Ayumi Nishikawa [Japon] ; Atsushi Ogata [Japon] ; Toshihiro Nanki [Japon] ; Kunihiro Hattori [Japon] ; Hitoshi Kohsaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Tsutomu Takeuchi [Japon] ; Tetsuji Naka [Japon] | Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis. |
002026 (2015) |
Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi Kumanogoh | Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab. |
002380 (2014) |
Atsushi Ogata [Japon] ; Kazuhide Tanimura ; Toyohiko Sugimoto ; Hiroshi Inoue ; Yukitomo Urata ; Tsukasa Matsubara ; Masakazu Kondo ; Yukitaka Ueki ; Mitsuhiro Iwahashi ; Shigeto Tohma ; Shuji Ohta ; Yukihiko Saeki ; Toshio Tanaka | Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis. |
002393 (2014) |
Toshio Tanaka [Japon] ; Yoshihiro Hishitani [Japon] ; Atsushi Ogata [Japon] | Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors. |
002522 (2014) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] | A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. |
003426 (2012) |
Atsushi Ogata [Japon] ; Toshio Tanaka | Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions. |
003460 (2012) |
Atsushi Ogata [Japon] ; Toru Hirano ; Yoshihiro Hishitani ; Toshio Tanaka | Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis. |
003471 (2012) |
Atsushi Ogata [Japon] ; Noriko Umegaki ; Ichiro Katayama ; Atsushi Kumanogoh ; Toshio Tanaka | Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab. |
003478 (2012) |
Atsushi Ogata [Japon] ; Atsushi Kumanogoh ; Toshio Tanaka | Pathological role of interleukin-6 in psoriatic arthritis. |
003548 (2012) |
Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio Tanaka | A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
003806 (2012) |
Atsushi Ogata [Japon] ; Noriko Umegaki [Japon] ; Ichiro Katayama [Japon] ; Atsushi Kumanogoh [Japon] ; Toshio Tanaka [Japon] | Rhumatisme psoriasique chez deux patients en échec de traitement par le tocilizumab |
003867 (2011) |
Yoshihito Shima [Japon] ; Tetsuya Tomita ; Taeko Ishii ; Atsuyoshi Morishima ; Yuichi Maeda ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis. |
003876 (2011) |
Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Therapeutic effect of tocilizumab on two patients with polymyositis. |
003888 (2011) |
Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio Tanaka | Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab. |
003A05 (2011) |
Atsushi Ogata [Japon] ; Atsuyoshi Morishima [Japon] ; Toru Hirano [Japon] ; Yoshihiro Hishitani [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] | Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab |
003A38 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
003B72 (2011) |
Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | Therapeutic effect of tocilizumab on two patients with polymyositis |
003C17 (2010) |
Toshio Tanaka [Japon] ; Atsushi Ogata ; Masashi Narazaki | Tocilizumab for the treatment of rheumatoid arthritis. |
003C43 (2010) |
Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio Tanaka | Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens. |
003C90 (2010) |
Yoshihito Shima [Japon] ; Yusuke Kuwahara [Japon] ; Hiroyuki Murota [Japon] ; Shun Kitaba [Japon] ; Mari Kawai [Japon] ; Toru Hirano [Japon] ; Junsuke Arimitsu [Japon] ; Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Atsushi Ogata [Japon] ; Ichiro Katayama [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab |
003E63 (2010) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab |
003F01 (2009) |
Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu Kishimoto | Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
003F40 (2009) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab |
004045 (2009) |
Toshio Tanaka [Japon] ; Yusuke Kuwahara [Japon] ; Yoshihito Shima [Japon] ; Toru Hirano [Japon] ; Mari Kawai [Japon] ; Masako Ogawa [Japon] ; Junsuke Arimitsu [Japon] ; Keisuke Hagihara [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] | Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab |